Linked Life Data

18646116

Source:http://linkedlifedata.com/resource/pubmed/id/18646116

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-7-22
pubmed:abstractText
Despite ongoing progress, acute and chronic GvHD still represent major drawbacks in the context of allogeneic myeloablative haematopoietic stem cell transplantation (HSCT) due to their high morbidity and mortality. Corticosteroids are used as first-line treatment of acute and chronic GvHD. However, their role for preventing GvHD is unclear as the published study results are controversial.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1469-493X
pubmed:author
pubmed:issnType
Electronic
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
CD004885
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation.
pubmed:affiliation
Cochrane Haematological Malignancies Group - Department of Internal Medicine 1, University Hospital of Cologne, Kerpener Str. 62, Cologne, Germany, 50924. s.quellmann@email.de
pubmed:publicationType
Journal Article, Review, Meta-Analysis